Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

CUTV News Radio spotlights Dr. Kenneth Blum of Geneus Health

  • Broadcast in Health
CUTV News Radio

CUTV News Radio


Follow This Show

If you liked this show, you should follow CUTV News Radio.

San Antonio, TX – The struggles associated with addiction are rivaled only by our struggle to understand it. Years ago, we believed addiction was psychological, spiritual, a question of willpower. Just say no. We now know that some people are actually genetically predisposed to engage in these behaviors.

Geneus Health is the world’s leading Genetic Addiction testing company.  Dr. Kenneth Blum, Chairman of the Board of Geneus Health has created with Dr. Jenifer Neary, and their associates a novel integrated system “Precision Addiction Management”™ that analyzers a person’s DNA called Genetic Addiction Risk Score (GARS™) to help people better understand their genetic predisposition toward addictive behavior.

You often hear alcoholism referred to as a disease, but alcoholism is not a disease. Drug addiction is not a disease. Neither is sex addiction, or shopping, internet gaming, gambling. They are subsets of a disorder known as “reward deficiency syndrome.” Dr. Blum coined the term “Reward Deficiency Syndrome” in 1995

“When people think about addiction, they think about the after-effects. They think about how the drugs are changing the brain state or the physiology of the body,” says Dr. Blum. “What we're looking at is a predisposition. If they try a drug or alcohol or behaviors like gambling or sex, how likely is it that that behavior will develop into an addiction.”

Genius Health is delivering the first true genetic addiction risk score using cutting edge technology to genotype your DNA and evaluate variations across the reward genes.

For more information on Geneus Health, visit www.GeneusHealth.com.